[(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate
C38H55N3O17 — CID 161039147
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate
[(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate (PubChem CID 161039147) has the molecular formula C38H55N3O17 and a molecular weight of 825.86 g/mol. Its IUPAC name is [(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate.
Molecular Properties
| Compound Name | [(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate |
|---|---|
| PubChem CID | 161039147 |
| Molecular Formula | C38H55N3O17 |
| Molecular Weight | 825.86 g/mol |
| Exact Mass | 825.35 |
| IUPAC Name | [(3S,6S,7R,8R)-6,8-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate;[(3S,6S,7R,8R)-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6,8-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate |
| SMILES | CC(C)C(=O)O[C@H]1[C@H](C)OC(=O)[C@@H](NC(=O)OC(C)(C)C)COC(=O)[C@@H]1C.COc1ccnc(C(=O)N[C@H]2COC(=O)[C@H](C)[C@@H](OC(=O)C(C)C)[C@H](C)OC2=O)c1O |
| InChI | InChI=1S/C20H26N2O9.C18H29NO8/c1-9(2)18(25)31-16-10(3)19(26)29-8-12(20(27)30-11(16)4)22-17(24)14-15(23)13(28-5)6-7-21-14;1-9(2)14(20)26-13-10(3)15(21)24-8-12(16(22)25-11(13)4)19-17(23)27-18(5,6)7/h6-7,9-12,16,23H,8H2,1-5H3,(H,22,24);9-13H,8H2,1-7H3,(H,19,23)/t10-,11+,12+,16-;10-,11+,12+,13-/m11/s1 |
| InChIKey | UAQQEXMCRJGRMX-HPSFLNBJSA-N |
| XLogP | 2.16 |
| TPSA | 267.58 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 825.86 |
| LogP ≤ 5 | 2.16 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161039147 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.